|
|
|
|
||
Abbvie, Lilly Face Fresh Delays in FDA approval for Arthritis Drugs FDA delays in the analysis of PFE's Oral Surveillance Safety Study has put off potential approvals for other JAKs https://www.medscape.com/viewarticle/954936?src=&utm_content=buffer30fed&utm_medium=social&utm_source=linkedin.com&utm_campaign=buffer |
return to message board, top of board |